The meth crisis is worse than ever, but new treatments might be around the corner
When it comes to meth addiction, Thomas Robey has long been at a loss. As an emergency room doctor, he treats a steady stream of patients who show up at …
Read MoreTag: drug development
Opinion: Needed: a clearer explanation of why diversity in clinical trials is important
Increasing the diversity of clinical trial participants is all the rage these days. The numbers tell the story: According to Food and Drug Administration data, in 2020 75% of trial …
Read More
Opinion: Reformulating drugs helps profits more than patients
Prescription drug prices remain stubbornly high in the U.S. even though making drugs more affordable is a priority for both Democrats and Republicans. There are many reasons for the lack …
Read More
Opinion: Preparing for the next pandemic: Time to follow a social business model for patent-free global medicine production
The World Health Assembly, which is meeting in Geneva for the first time since the pandemic began, has agreed to set a framework to begin preparing for future pandemics. But …
Read More
Coronavirus hasn’t developed resistance to Paxlovid. How long can that last?
When the patient came back 10 days later, coughing repeatedly and complaining of headache, Davey Smith feared the worst. Smith had prescribed the patient Pfizer’s new antiviral pill, Paxlovid, on …
Read More
National Academies report cites ‘urgent’ need to recruit more diverse participants for clinical trials
The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and …
Read More
As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox. It’s UFA week …
Read More
FDA approves Lilly diabetes drug that analysts expect to be a big seller
The Food and Drug Administration said Friday it had approved Mounjaro, a new injection for type 2 diabetes made by Eli Lilly that lowers blood sugar and can help patients …
Read More
Opinion: Exploitation in the name of biomedical innovation cannot be tolerated
Biogen’s announcement on Tuesday that it is “substantially eliminating” its spending on Aduhelm caps a remarkable story of drug development gone bad. In a controversial move in June 2021, the …
Read More